Lipid-based amphotericin B in the treatment of cryptococcosis
- 1 March 1994
- journal article
- special addendum
- Published by Springer Nature in Infection
- Vol. 22 (2) , 137-142
- https://doi.org/10.1007/bf01739025
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDSAIDS, 1993
- Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosisAntimicrobial Agents and Chemotherapy, 1992
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- Short-Course Treatment and Response to Liposomal Amphotericin B in AIDS-Associated CryptococcosisThe Journal of Infectious Diseases, 1992
- Safety and Efficacy of Liposomal Amphotericin B in Treating AIDS-Associated Disseminated CryptococcosisThe Journal of Infectious Diseases, 1991
- Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin BAIDS, 1991
- Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patientsJournal of Antimicrobial Chemotherapy, 1991
- Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trialJournal of Antimicrobial Chemotherapy, 1991
- Amphotericin B: delivery systemsAntimicrobial Agents and Chemotherapy, 1990
- Treatment of Murine Cryptococcosis with Liposome-Associated Amphotericin BThe Journal of Infectious Diseases, 1982